ArticleJournal of clinical medicine2021

Ciclesonide Inhaler Treatment for Mild-to-Moderate COVID-19: A Randomized, Open-Label, Phase 2 Trial.

Joon-Young Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.